The Department of Medicine is pleased to announce that Nadine Rouphael, MD, professor in the Division of Infectious Diseases, has been named executive director of the Hope Clinic, the clinical arm of the Emory Vaccine Center, effective February 1, 2021. She has served as the interim director of the Hope Clinic since 2018 and director of the Emory Vaccine and Treatment Evaluation Unit (VTEU) at the Hope Clinic since 2013.
Rouphael also serves as director of the Emory Human Immunology Project Consortium at the clinic and associate director of the Vaccinology T32 Program. She has an outstanding record of scholarship, service, and leadership in building Emory’s nationally recognized translational vaccinology and therapeutic clinical trials program at the Hope Clinic. She has also made critical contributions to the development of COVID-19 therapeutics and vaccines.
Please join us in congratulating Rouphael on this outstanding accomplishment. We are incredibly proud of her dedicated work during the pandemic.
Related Links
- Nadine Rouphael, MD, conducts groundbreaking COVID-19 vaccine research
- The Hope Clinic of the Emory Vaccine Center
- Division of Infectious Diseases
Be the first to comment on "Nadine Rouphael, MD named executive director of the Hope Clinic of the Emory Vaccine Center"